General understanding of early repolarisation (ER) has dramatically changed in the last decade. For several years, ER has been considered a benign electrocardiographic (ECG) finding with high prevalence in the general population. Recently different studies have challenged this view and showed a significant association with life-threatening arrhythmias. [1] [2] [3] [4] [5] In 2008 Haïssaguerre et al. first reported an increased prevalence of a particular pattern of ER on the resting 12-lead ECG of patients with history of idiopathic ventricular fibrillation (VF) (see Figure 1) . 2 In these patients, ER was characterised by elevation of the QRS-ST segment junction of at least 0.1 mV above the baseline level, manifesting as QRS slurring (a smooth transition from the QRS complex to the ST segment) or notching (a positive J deflection of at least 1 mm inscribed on the S wave) in two adjacent inferior (II, III and aVF), lateral (I, aVL, and V4-V6), or infero-lateral leads. The ER pattern was observed in 31 % of patients with idiopathic VF and in 5 % of healthy control subjects.
segment, confers the highest arrhythmic risk. Conversely, ascending ST segment has not been found associated with a higher risk of lifethreatening arrhythmias. Finally, ST segment in the absence of a slur or a notch should be considered as nonspecific ST-segment elevation rather than ER pattern. 7 
Brugada Syndrome and Early Repolarisation
Brugada syndrome (BrS) is an inheritable syndrome characterised by an increased risk of sudden cardiac death (SCD) in patients without overt structural cardiac abnormalities. 6, 9 The Brugada brothers first described the disease as a new distinct clinical and electrocardiographic entity in 1992. 9 The initial report included a series of eight patients presenting with incomplete right bundle branch block, ST-segment elevation on 12-lead ECG and susceptibility to sustained ventricular arrhythmias. All the patients had no electrolytic or ischaemic disturbances nor obvious structural heart disease that could explain the ECG findings. 9 Interestingly, an ECG pattern similar to coved-type ST-segment elevation was previously reported as a normal variant in the healthy population or related to VF in patients with structural cardiac abnormality. 10, 11 Subsequently, a group of Italian researchers considered it as a form of arrhythmogenic right ventricular cardiomyopathy. 12 The identification of the first putative casual gene mutation in 1998 clarified the controversy confirming the genetic nature of the disease. 13 Over the past two decades a considerable number of studies, including reports of two consensus conferences, contributed to definition of the clinical characteristics, and of cellular and molecular features associated with the disease. [14] [15] [16] [17] [18] Three different ECG patterns have been identified in patients with BrS (see Table 1 ). Although all three patterns can be present in BrS and even in the same patient at different times, only type 1 ECG is considered diagnostic of the syndrome. [17] [18] [19] [20] In fact, according to the last expert consensus document on inherited primary arrhythmia syndromes, BrS is definitively diagnosed when a type 1 ST-segment elevation is observed either spontaneously or after intravenous administration of a sodium channel blocking agent in at least one right precordial lead (V1 and V2), placed in a standard or a superior position (up to the second intercostal space). 6 Moreover, in 2012 a group of experts produced a consensus document on ECG criteria outlining a number of new features that can help to identify the Brugada type 1 ECG. According to this document, the ECG pattern, to be considered as type 1, has to display:
• ST-segment elevation with the highest point of QRS-ST of at least 2 mm in lead V1;
• Coved-type morphology (concave or rectilinear, followed by a negative and symmetrical T-wave);
• Progressive decline of the ST-segment morphology (the high take-off is always higher than 40 ms later and this is, in turn, higher than after 80 ms);
• Slow ST-segment descent after the QRS peak (<0.4 mV at 40 ms);
• Ratio of peak height of QRS-ST: peak of ST segment after 80 ms >1
• Greater duration of QRS complex in V1 and V2 than in middle and left precordial leads;
• Location in V1 or V2 but never exclusively in V3;
• Absence of a wide S-wave in lead I and V6.
Moreover, given the minimal morphological differences between type 2 and type 3 and the lack of impact on prognosis, both patterns have been unified in the type 2 ECG.
19
The heterogeneity of BrS can lead some patients to present with additional repolarisation abnormalities such as ER signs in the inferolateral leads (see Figure 2) . 21, 22 Up to 12 % of patients with BrS have the infero-lateral ER pattern. It is more frequently associated with type 1 ECG and previous symptoms, although no significant association with a worse outcome was reported, as shown by a multicentre study. 21, 22 Patients with BrS experiencing electrical storms have a higher prevalence of ER pattern. 23 Moreover, Kawata et al. reported ER pattern in up to 63 % of patients with BrS and documented VF and a worse outcome when ER pattern was persistent. 24 It is worth noting that previous studies on ER syndrome have potentially included patients with BrS and nondiagnostic baseline ECG. A very recent study has, in fact, shown that up to 30 % with an initial diagnosis of ER syndrome display spontaneous Brugada type 1 in the high intercostal right precordial leads only, and most VF recurrences occur in patients with ER pattern and Brugada type 1 ECG documented in any of the right precordial leads. 25 Based on such findings, sodium channel blocker challenge and ECG recording in high intercostal spaces should be performed in any case of unexplained VF and documented ER pattern in order to exclude the presence of a channelopathy. In BrS, repolarisation signs can coexist with depolarisation abnormalities and a combination of such findings seems to confer an even higher risk of further arrhythmic events. 26, 27 Tokioka et al. reported a combination of ER pattern and fragmented QRS in 3.6 % of patients with BrS. Both ER pattern and fragmented QRS were identified as independent predictors of further arrhythmic events, and patients with both ERP and fragmented QRS had a significantly higher frequency of arrhythmic events than did those who had neither ER nor fragmented QRS. 27 
Overlapping Features of Brugada and Early Repolarisation Syndromes
Brugada and ER syndromes are two primary electrical disorders named J-wave syndromes by some investigators. 28 Both clinical entities present with distinct ECG abnormalities affecting the junction between the terminal portion of the QRS complex and the beginning of the ST segment. In addition, the two syndromes seem to share a common channelopathy asset that leads to an increased risk of SCD (see Table   1 ). Antzelevitch and Yan revealed that the presence of an outward shift of balance in repolarising currents in canine wedge preparations, caused by a decrease in sodium or calcium channel currents or an increase in outward potassium currents, creates a notch in the action potential of the epicardium, resulting in a transmural voltage gradient. 29 Accentuation of such condition in the right ventricular outflow tract gives rise to BrS coved-type ECG in the right precordial leads; whereas if the infero-lateral ventricle is affected, a J-point elevation, distinct J-wave or end-QRS slur can manifest in the inferior and/or lateral leads.
Brugada and ER pattern can manifest spontaneously or be concealed, becoming apparent only under certain conditions such as fever, high vagal tone, sodium channel blocker challenge (for BrS) or Valsalva manoeuvre (for ER syndrome). 30, 31 For both syndromes, most prominent ECG changes appear just before the onset of ventricular arrhythmias. 2, 32 An additional characteristic shared by patients with Brugada and ER pattern is related to the intermittent nature and dynamicity of the ECG pattern over time. Moreover, the ECG phenotype can differ with gender and age categories of patients. 33, 34 Even the response to ajmaline in BrS can be age dependent. 35 The clinical value of repeating ajmaline challenge after puberty in asymptomatic family members with prepubertal negative drug test was recently reported. 35 Apart from the ECG, BrS and ER syndrome have several clinical similarities. They present both a highly variable clinical expressivity ranging from a lifelong course to sudden death even in the first months of life. 36 Male predominance is a common characteristic. 2, 33 Moreover, sudden death usually occurs in the third or fourth decade of life. 2, 36 Ventricular fibrillation is triggered by short-coupled premature ventricular complexes and arrhythmic episodes occur at rest or during sleep. Additionally, they both respond well to quinidine, isoproterenol and cilostazol, explained by the effect of these agents on inhibition of potassium currents or increase of calcium currents. 37 Apart from the similar ECG and clinical phenotype, some differences can be also appreciated between the two entities. They include: 
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In a multicentre study of patients with ER syndrome and aborted sudden death, inducibility of sustained VF during electrophysiology study was relatively infrequent in idiopathic VF survivors (22 %) and did not predict any further arrhythmia during the long-term follow-up. 41 In BrS there are many controversies regarding the prognostic role of EP study. 42 Although large studies agree that electrophysiological study inducibility is greatest among BrS patients, there has been no consensus on the value of the EP study in predicting outcome. 6, 43, 44 Several consensus documents have addressed this issue and the current recommendation is to implant an ICD in inducible patients (Class IIb indication). 
ECG is characterised by a coved-type ST-segment elevation ≥2 mm in at least one right precordial lead (V1-V3), followed by symmetric negative T waves, with little or no isoelectric separation. **Type 2 ECG displays a ST-segment elevation of >2 mm in right precordial leads followed by positive or biphasic T waves, resulting in a saddleback configuration. ***Type 3 ECG is defined as any of the two previous types if ST-segment elevation is ≤1 mm. ¥ ER pattern is characterised by a notch or slur ≥1 mm, occurring on the final 50 % of the downslope of an R-wave, in two adjacent inferior (II, III and aVF), lateral (I, aVL and V4-V6), or infero-lateral leads. § f-QRS (fragmented QRS) presents as a notch midway on the downslope of an R-wave. BrS = Brugada syndrome; ER syndrome = early repolarisation syndrome.
subunits of the potassium, calcium and sodium channel structures. 47 BrS has been associated with mutations in 19 different genes, whereas ER syndrome has been associated with mutations in seven genes.
The first gene associated with ER syndrome was KCNJ8, which encodes a pore-forming subunit of the ATP-sensitive potassium channel (K ir 6.1-I kATP ). The KCNJ8-S422L variant mutation was first described in a young female with ER pattern and frequent episodes of VF. 48 Subsequently, loss of function mutations was found in the SCN5A gene and L-type calcium channel genes (LTCC, CACNA1C, CACNB2, CACNA2D1) in patients with idiopathic VF and ER. 49, 50 Moreover, genetic variants have been identified in the ABCC9 gene, encoding the ATP-binding cassette transporters of ATP-sensitive potassium channels. 51 All these gene mutations associated to ER syndrome might enhance the underlying inward-outward current imbalance responsible for accelerated epicardial repolarisation.
Known genes only account for a small proportion of patients. 52 Only a small fraction of identified genetic variants has been examined by use of functional expression studies to establish causality or the potential contribution to the pathogenesis of the disease. BrS and ER syndromes can present as familial or isolated cases. 53 Malignant familial forms of ER have been reported to be transmitted as an autosomal dominant trait in three large French families. 54 Similarly, inheritance in BrS occurs via an autosomal dominant mode of transmission with incomplete penetrance.
Most individuals diagnosed with BrS have an affected parent. The
proportion of sporadic cases caused by de novo mutation is lower. 53 Moreover, the yield of DNA testing in BrS is higher in familial cases (44 %) as compared with isolated cases (21 %). 52 After the identification in 1998 of the first gene linked to BrS, the SCN5A gene encoding for the alpha subunit of the cardiac sodium channel, other responsible genes have been reported. 13, 55 In all genotypes, either a decrease in the inward sodium or calcium current, or an increase of the outward potassium currents has been shown to be associated with the BrS phenotype. Genetic abnormalities are found in up to onethird of genotyped patients, and for the SCN5A gene alone more than 300 mutations have been described. 56 Reported mutations include missense mutation, nonsense mutation, nucleotide insertion/deletion and splice site mutation. Loss of function of the sodium channel, which impairs the fast upstroke in phase 0 of the action potential, occurs because of decreased expression of Na v 1.5 proteins in the sarcolemma, expression of non-functional channels, or altered gating properties (delayed activation, earlier inactivation, faster inactivation, enhanced slow inactivation and delayed recovery from inactivation). 57 The specific type of SCN5A mutation may affect the phenotype. In fact it has been reported that mutations leading to a stop codon, where no sodium channel is created, or missense mutation with >90 % peak sodium current reduction seem to be associated with a poorer prognosis compared with mutations resulting in loss-of-function. 58 Reduced sodium current and BrS phenotype can also be due to sodium and calcium channel-associated proteins: GPD1-L, SCN1B and SCN3B. Moreover, lossof-function mutations in the l-type calcium channel (LTCC) genes encoding for the a and b subunits of the cardiac calcium channel can cause BrS.
Putative casual mutations have been also found in genes that regulate transient outward potassium current (KCNJ8, KCNE3, KCND3, KCNE5).
A recent comprehensive mutational analysis of 12 known BrSsusceptibility genes in a large cohort of unrelated BrS patients identified SCN5A mutations in 16 %, with the other genes accounting for <5 % of patients. 55 The lack of familial segregation data of many susceptibility genes, the relatively frequent association of BrS with common genetic variants and the lack of functional studies remain a major limitation of the genetic testing in BrS.
According to the last consensus document on channelopathies, genetic testing in BrS is not recommended in the absence of a diagnostic ECG.
On the other hand, it may be useful and is recommended for family genetically screened 87 probands with BrS and 14 with ER syndrome and found 1 BrS and ER syndrome proband with a S422L-KCNJ8 mutation; the variation was absent in 600 controls. 61 Similarly, Barajas- Martinez et al. reported the same missense mutation, p.Ser4222Leu in KCNJ8 in 3 BrS and 1 ER syndrome proband. 62 Cases of ER syndrome are often associated with electrical storms in which defects in genes traditionally causing BrS, such as SCN5A, are involved and in combination with mutations in I kATP genes. 51 A SCN5A mutation can lead to varying degrees of the Brugada ECG phenotype in members of the same family: in some of them repolarisation abnormalities can occur in the inferior leads only, whereas in others the right precordial leads are characteristically affected. 63 This might be related to a different or additional spatial localisation of the affected cardiomyocyte within the heart, other than the right ventricular outflow tract.
A complex genetic inheritance known as the oligogenic model has been recently hypothesised to explain particular clinical presentation of inherited cardiac diseases. 47 In contrast to the monogenic paradigm, where a strong monogenic component is responsible of the disease susceptibility, for other diseases such as BrS or ER syndrome inheritance of many genetic risk variants can occur. In addition, the presence of modulating factors may contribute to the manifestation of the disease with a mixed phenotype. 
